Detecting signals of drug-drug interactions in a spontaneous reports database

British Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2007, Pages 489-495

  Thakrar, Bharat T ^a   Grundschober, Sabine Borel ^a   Doessegger, Lucette ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Drug drug interactions; Measure of interaction; Multiplicative and additive models

Indexed keywords

AZITHROMYCIN; CISAPRIDE; CYCLOSPORIN A; DICLOFENAC; ERYTHROMYCIN; FEXOFENADINE; FLUINDOSTATIN; KETOCONAZOLE; METHOTREXATE; ROFECOXIB; SIMVASTATIN; TERFENADINE;

ARTICLE; BONE MARROW DEPRESSION; DATA BASE; DRUG ELIMINATION; DRUG MECHANISM; DRUG MONITORING; FOOD AND DRUG ADMINISTRATION; HUMAN; MYOPATHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TORSADE DES POINTES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG INTERACTIONS; MODELS, CHEMICAL; PHARMACEUTICAL PREPARATIONS;

EID: 34548608965     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02900.x     Document Type: Article

References (11)

1. Evans S, Waller P, Davis S. Use of PRRs for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Safety 2001 10 : 483 6.
2. Van Puijenbroek P, Egberts CG, Meyboom RHB, Leufkens HGM. Signalling possible drug interactions in a spontaneous reporting system: delay of withdrawal bleeding using concomitant use or oral contraceptives and itraconazole. Br J Clin Pharmacol 1999 47 : 689 93.
3. Van Puijenbroek P, Egberts CG, Heerdink ER, Leufkens HGM. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol 2000 56 : 733 8.
4. Laine K, Forsstrom J, Gronroos P, Irjala K, Kailajarvi M, Scheinin M. Frequency and clinical outcome of potentially harmful drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards: focus on warfarin and cisapride. Ther Drug Monit 2000 5 : 503 9.
5. Stockley I. ed. Stockley's Drug Interaction, 6th edn. London, Pharmaceutical Press, 2002.
6. Cadieux R. Drug interactions in the elderly. Postgrad Med 1989 86 : 179 86.
7. Tinawi M, Alguire P. The prevalence of drug interactions in hospitalized patients. Clin Res 1992 40 : 773A.
8. McCullagh P, Nelder J. Generalized linear models. London, Chapman & Hall, 1989.
9. Almenoff JS, DuMouchel W, Kindman L, Xionghu W, Fram D. Disproportionality analysis using empirical bayes data: a tool for the evaluation of drug interactions. Pharmacoepidemiol Drug Safety 2003 12 : 517 21.
10. Yang X, Fram D. Using disproportionality analysis as a tool to explore drug-drug interavtions in AERS database. Pharmacoepidemiol Drug Safety 2004 13 : S247.
11. Zhou H. Population-based assessment of clinical drug-drug interactions: quantitative indices or qualitative measures. J Clin Pharmacol 2006 46 : 1268 89.